Canada · Health Canada Drug Product Database
TRAVASOL
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11329
- DIN
- 00872296
- Form
- Solution
- Company as listed by source
- BAXTER CORPORATION
- Source status
- Marketed (2013-10-16)
- Source last updated
- 2026-06-23
Source-listed ingredients
- LEUCINE — 730 MG — per 100 ML
- PHENYLALANINE — 560 MG — per 100 ML
- METHIONINE — 400 MG — per 100 ML
- L-LYSINE (L-LYSINE HYDROCHLORIDE) — 580 MG — per 100 ML
- ISOLEUCINE — 600 MG — per 100 ML
- VALINE — 580 MG — per 100 ML
- HISTIDINE — 480 MG — per 100 ML
- THREONINE — 420 MG — per 100 ML
- TRYPTOPHAN — 180 MG — per 100 ML
- L-ALANINE — 2.07 G — per 100 ML
- GLYCINE — 1.03 G — per 100 ML
- ARGININE — 1.15 G — per 100 ML
- PROLINE — 680 MG — per 100 ML
- TYROSINE — 40 MG — per 100 ML
- SERINE — 500 MG — per 100 ML
These values do not establish equivalence or a dose recommendation.
Packages
- 3000
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →